Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03386812 · ClinicalTrials.gov registry record

Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer

A clinical trial, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
19
Enrollment target

NCT03386812 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03386812 has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
19 participants
Enrollment target

Study Summary

The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prostate cancer. The investigators will measure changes in serum biomarkers involved in muscle-bone crosstalk, anatomic changes in muscle and bone structure and strength that could ultimately contribute to fractures. The findings from this research will inform design of interventions to reduce falls and hip fractures in patients undergoing ADT as well as application to broader populations of at risk patients.

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2017-10-01
Est. Completion 2020-11-29

What the Registry Record Tells You About NCT03386812

The ClinicalTrials.gov registry entry for NCT03386812 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03386812 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03386812 about?

NCT03386812 is a clinical study titled "Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer". The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prostate cancer. The investigators will measure changes in serum biomarkers involved in muscle-bone crosst...

What is the current status of trial NCT03386812?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-10-01. Estimated completion is 2020-11-29.

Who is sponsoring clinical trial NCT03386812?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.